Ann: ResAppDx to be Formally Evaluated by Doctors Without Borders, page-51

Nice one @GCInvestor . I figured as much. When you deal with organisations of that size you can't afford to make mistakes in wording or intent. They rely on funding from many sources and making silly mistakes could hurt that funding.

Some people have also stated that a clinical study would take a long time. I highly doubt that as MSF has already been engaged for a while and they would now just have to inject the RAP app into currently used processes....if they haven't already to some degree. It will be t crossing and i dotting for that study to kick off.